Moreover, USP22 can be transcriptionally upregulated by HIF1α, creating a positive feedback loop that amplifies stemness characteristics and reduces the sensitivity of HCC cells to sorafenib [165]. This evidence concerns the gene HIF1A and hepatocellular carcinoma.